Freestone Grove Partners LP
Position in ELAN — Elanco Animal Health Inc
CIK 2007591
San Francisco, CA
Position in ELAN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,420,459
-$23,945,780 QoQ
Shares Held
2,170,681
-43.5% QoQ
Ownership
0.434%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#40
of 518 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Freestone Grove Partners LP holds $100,700,353 across 12 Drug Manufacturers - Specialty & Generic names. ELAN ranks #1 (53.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
This page
|
2,170,681 | $53,420,459 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
604,053 | $20,465,315 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
316,398 | $14,715,670 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
101,332 | $8,388,262 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
44,493 | $1,610,646 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
18,079 | $854,594 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
1,207 | $653,988 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
4,615 | $295,129 |
All Filings in ELAN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,420,459 | 2,170,681 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $77,366,239 | 3,841,422 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $54,992,994 | 3,851,050 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $33,677,017 | 3,207,335 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,395,540 | 1,684,190 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||